首页 | 本学科首页   官方微博 | 高级检索  
     

中西医结合治疗晚期肺癌临床研究
引用本文:陈绪元,雷自重,何方志. 中西医结合治疗晚期肺癌临床研究[J]. 肿瘤学杂志, 2003, 9(2): 88-90
作者姓名:陈绪元  雷自重  何方志
作者单位:重庆医科大学附属第一医院,重庆,400016
摘    要:[目的]探讨中西医结合治疗晚期肺癌的增效减毒作用。[方法]对30例晚期肺癌患者采用中医辨证治疗加化放疗(A组)并与30例单纯行化放疗(B组)患者进行比较。[结果]A、B两组近期有效率分别为90.0%、80.0%;中位生存期A组为17.5个月,B组为13个月;1、3、5年生存率两组未见统计学差异(P>0.05),但A组患者生活质量、免疫功能、毒副反应明显改善(P<0.05)。[结论]中西医结合治疗晚期肺癌有增效减毒,调节免疫功能,改善生活质量,延长生存期的作用。

关 键 词:中西医结合治疗 晚期 肺癌 减毒作用 中医辨证治疗 化疗 放疗
文章编号:1671-170X(2003)02-0088-03
修稿时间:2002-09-16

Clinical Study on Combination of Traditional and Western Medicine for the Treatment with Advanced Lung Cancer
CHEN Xu - yuan,LEI Zi - zhong,HE Fang - zhi. Clinical Study on Combination of Traditional and Western Medicine for the Treatment with Advanced Lung Cancer[J]. Journal of Chinese Oncology, 2003, 9(2): 88-90
Authors:CHEN Xu - yuan  LEI Zi - zhong  HE Fang - zhi
Abstract:To evaluate the clinical efficacy of the combination of traditional and western medicine for advanced lung cancer and its synergism with radiotherapy or chemotherapy.Thirty pa-tients in the group A were treated with traditional Chinese medicine combined with radiotherapy and chemc-therapy,and the30patients in the group B treated with radiotherapy and chemotherapy.The short term response rate in the group A,B were90.0%and80.0%respectively.The median survival in the two groups were17.5and13months respectively.The1-,3-and5-year survival rates in the group A were similar with those in the group B(P>0.05).However,karnofsky scoring,immunity and side effects were obviously im-proved in the group A(P<0.05).[Conclusion]Traditional Chinese medicine combined with radiotherapy and chemotherapy can reduce the toxicoty,regulate the cell mediated immunity of patients,elevate quality of life and prolong survival time of patients with advanced lung cancer.
Keywords:lung neoplasms  traditional Chinese medicine  radiotherapy  drug therapy  efficacy
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号